Although AFP, as a star marker, has currently been utilized in clinical settings for the detection of various cancers, including HCC, gastric cancer, and breast cancer (Sun et al., 2017; Zhan et al., 2022), to date, there is no SPR aptasensor for AFP. This evidence concerns the gene AFP and breast carcinoma.